Pre-order item: This product is available to reserve now and is expected to ship between 13 July 2026 and 17 July 2026.
Selective Ghrelin Receptor Agonist (GHRP)
Ipamorelin (10mg) is supplied in Australia by Aussie Peptides with fast domestic shipping to all states and territories.
Ipamorelin is a selective ghrelin receptor (GHS-R1a) agonist studied for pulsatile growth hormone release that mimics the body's natural GH release pattern. Unlike earlier secretagogues (GHRP-2, GHRP-6), Ipamorelin's receptor selectivity is associated with minimal cortisol and prolactin elevation in research models.
Ipamorelin is commonly studied alongside CJC-1295 (no DAC) for synergistic activation of complementary pathways: GHRH-receptor stimulation plus ghrelin-receptor stimulation.
Key Research Areas
Pulsatile GH Release — Triggers pituitary GH pulses without significant cortisol or prolactin elevation Body Composition — GH/IGF-1 axis studied for protein synthesis and lean mass research Fat Mobilisation — GH-mediated lipolysis studied for visceral adipose tissue reduction Tissue Repair — Studied for connective tissue, muscle, and joint repair via GH signalling Sleep Architecture — GH release is nocturnal; pulse-pattern alignment studied in sleep research Age-Related GH Decline — Studied for restoring pulsatile GH secretion in aged models
Supplied as lyophilized powder, verified by HPLC and mass spectrometry. 10mg per vial. Fast domestic shipping across Australia, with batch-specific CoA information available in our CoA Library.
⚠ For in-vitro research and laboratory use only. Not for human consumption.
⚠ For in-vitro research and laboratory use only. Not intended for human or veterinary use. By purchasing, you confirm you are a qualified researcher and will use this compound in accordance with all applicable laws and regulations.